{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/51144-050#drug","name":"ADCETRIS","alternateName":"brentuximab vedotin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"51144-050"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA125388"},{"@type":"PropertyValue","propertyID":"UNII","value":"7XL5ISS668"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"3904f8dd-1aef-3490-e48f-bd55f32ed67f"}],"activeIngredient":"BRENTUXIMAB VEDOTIN","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"SEAGEN INC."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA125388","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51144-050"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-29T11:13:04.633Z"}}